That's a great PR, thanks for sharing. To me it reads like there's a lot of cool stuff in the pipeline, but gears are turning slow enough that most of the big announces would happen next year if stuff goes according to plan. No mention of audit progress or uplist, but that's more market-focused and might be something to present elsewhere.
All this red on the ticker could be flippers who were hoping for bigger IPF Immune launch news. So far it's not unusually high volume, just a lot of selling.
News 
Market Data 
Discover 
